Skip to main content

Table 2 Risk of new CVD events more than one year after first CVD event relative to healthy subjects

From: Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

Health state

Secondary event

Probability of later event

Comment

  

Value

Low

High

 

Post AMI

AMI*

3.05

1.47

4,60

DANAMI-2 [25]

Post AMI

Angina*

21.7

15.8

27.6

Zijlstra [20]

Post AMI

Dying (30-59 years)*

3.55

  

OPTIMAAL [26], DANAMI-2 [25], and RIKS-HIA [18]

Post AMI

Dying (60-69 years)*

2.36

  

OPTIMAAL [26], DANAMI-2 [25], and RIKS-HIA [18]

Post AMI

Dying (70 years or more)*

1.00

  

OPTIMAAL [26], DANAMI-2 [25], and RIKS-HIA [18]

Post AMI

Stroke*

2.77

2.08

3.47

Zijlstra [20]

Post angina

AMI (men)

3.88

2.24

5.60

OPTIMAAL [26]

Post angina

AMI (women)

1.17

0.76

1.59

OPTIMAAL [26]

Post angina

Angina*

11.32

8.30

14.29

Assumed to be half of the probability first year, SMM-report nr 5/2002 [27]

Post angina

Death

1.23

0.82

1.65

Assumed to be half of the probability first year, SMM-report nr 5/2002 [27]

Post angina

Stroke (men)

5,34

  

NOKC-report nr 8/2004 [28]

Post angina

Stroke (women)

5,26

  

Based on meta-analyses from Nordmann [29] + HKS [9]

Post stroke

AMI

3.51

1.78

5.33

Risks based on relationship between angina and well first year after angina

Post stroke

Death

4.91

3.86

5.97

Risks based on relationship between angina and well first year after angina

Post stroke

Stroke

2.82

1.81

3.48

van Wijk [30]

Heart failure

dying 2nd year after HF (women)

6.67

6.16

11.04

van Wijk [30] and SSB [31]

Heart failure

dying 3rd year after HF (women)

7.61

5.08

10.15

van Wijk [30]

Heart failure

dying later years after HF (women)

2.45

0.90

4.00

Rosolova, Euroheart 2 [14]

Heart failure

dying 2nd year after HF (men)

5.05

3.24

6.86

Rosolova, Euroheart 2 [14]

Heart failure

dying 3rd year after HF (men)

4.62

2.90

6.33

Rosolova, Euroheart 2 [14] and SSB [31]

Heart failure

dying later years after HF (men)

2.13

0.96

3.31

Rosolova, Euroheart 2 [14]

Heart failure

Stroke*

6.80

3.40

13.61

Rosolova, Euroheart 2 [14]

Heart failure

Worsening of HF

9.58

9.04

10.13

Rosolova, Euroheart 2 [14] and SSB [31]

Heart failure

AMI after HF (men)

1.5

0.6

3.8

Based on SAVE [32] and SOLVD [33]

Heart failure

AMI after HF (women)

4.1

1.8

9.3

Cleland, Euroheart [15]

Moderate stroke sequelae

AMI

4.41

3.32

5.28

Based on Mosterd et.al. [34]

Moderate stroke sequelae

heart failure

2

1

4

Based on Mosterd et.al. [34]

Moderate stroke sequelae

New stroke

4.30

3.92

4.62

Based on meta-regression from Touzé et.al. [35]

Moderate stroke sequelae

Dying

2

1.5

2.5

Expert opinion (ISK)

Severe stroke sequelae

Dying

3

2.25

3.75

Meta-analysis of Hillen [36] and Caro [37]

  1. *Adjusted down in the model because the data stems from RCT's